New CKM guideline urges team-based care, yet UH data show major therapy gaps; CINEMA model boosts outcomes amid cost, trust, and handoff hurdles.
|Articles|September 1, 2001
Supplements and Featured Publications
- Depression and Generalized Anxiety Disorder: Managed Care Considerations
- Volume 7
- Issue 11 Suppl
Introduction
Author(s)Michael E. Thase, MD
Advertisement
Articles in this issue
about 25 years ago
Participating Facultyabout 25 years ago
The Pharmacoeconomics of Venlafaxine in DepressionAdvertisement
Related to this article
Obesity care surges with GLP-1 demand, but fragmented ownership, prior authorizations, and coverage rules stall treatment—pharmacists step in.
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves Imlunestrant Plus Abemaciclib for Breast Cancer
2
FDA Approves First Treatment for Sanfilippo Syndrome Type A
3
Higher CPAP Adherence Linked With Lower Mortality Risk in OSA
4
World Alzheimer Day: Young-Onset Alzheimer Disease Often Misdiagnosed
5